Chloropsis Consulting LLP

Chloropsis Consulting LLP is listed as a small consultant research supplier in the Scientist.com network, with 1 site in 1 country.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1

Countries 1

Type of company: Small consultant

Biomarker Discovery Identify a biomarker associated with disease progression of disease, effectiveness of therapy or diagnosis of disease or condition.
Biomarker Services Evaluating normal/abnormal biological conditions and characteristics within the body
Diagnostic Biomarkers Discovery Identify candidate biomarkers indicative of the presence of a disorder.
Multi-Omics Study Use an integrated multi-omics study to understand a disease mechanism.
Pharmacodynamic Biomarkers Discovery Identify candidate biomarkers indicative of the therapeutic outcome of a drug-target interaction.
Predictive Biomarkers Discovery Identify candidate biomarkers suggestive of a response to a treatment.

Show all 7 in Biomarkers 1 more

Prognostic Biomarkers Discovery Identify candidate biomarkers representative of disease progression without treatment.

Drug Repurposing Discovering new therapeutic uses for existing drugs that are outside the scope of the original medical indication.

Bioinformatics Consulting Consulting Services for the science of collecting and analyzing complex biological data
Consulting Services Work with consultants who provide expert advice in various areas of research and technology.
Pathophysiology Consulting Request services related to Pathophysiology Consulting
Target Validation Consulting Help to demonstrate that modification of target activity has potential therapeutic benefits.

Target Identification Identify the target(s) of a biologically active substance.

Show all 28 services 16 more

Disease or Drug-Related Literature Curation, development, and compliant distribution of written materials (e.g., abstracts, manuscripts, summaries) related to a specific illness or medicinal product.
Landscape Analysis Find a cohesive and consistent view of your main organization. Develop initiatives in analyzed areas of operations and analyze chosen key aspects of them.
Market & Competitor Analyses Evaluating the current therapeutic landscape, identifying unmet needs, and assessing the scientific positioning and data of competitor products.
Medical Literature Reviews Systematic searching, appraisal, and synthesis of published scientific literature to generate evidence-based reports on a specific topic, disease, or treatment.
Scientific Platform Develop a rigorous approach to creating a core story (grounded in the scientific literature) for a product. This involves identifying core concepts that address disease states, clinical needs, and product-related...
Scientific Positioning Strategic development of the evidence-based argument that defines how a drug or therapy is distinct, superior, or beneficial relative to competitors in the market.

Show all 7 in Medical Communications 1 more

Therapy Area Disease Insights Report Creation of a comprehensive analysis of the current scientific, clinical, and competitive landscape within a specific therapeutic area.

Asset Prioritization Studies Assesses stakeholder interest and unmet need across multiple assets in development. Helps pipeline teams allocate investment and identify lead candidates.
Competitive Landscape Research Maps competitor products, positioning, trial activity, and perception among stakeholders. Delivers inputs for SWOT analysis and differentiation strategy.
Early Concept Testing Evaluates initial ideas or positioning strategies with target audiences before refinement. Provides go/no-go input and direction for further development.
Positioning and Value Proposition Testing Tests various positioning statements and value messages with target audiences. Refines messaging to maximize resonance and differentiation.
Target Product Profile (TPP) Testing Tests stakeholder reactions to hypothetical product profiles across key attributes. Guides clinical development prioritization and access positioning.
Unmet Need and SoC Validation Assesses perceived gaps in current standards of care and the need for new interventions. Supports value proposition development and market shaping.

Clinical Phenotype Data Obtain phenotypic data and observations on patients such as the clinical manifestation of the disease, clinical and behavioral parameters, symptoms, and laboratory test results.

Marker Analyses Identify associations between genetic markers and traits of interest to determine markers responsible for human diseases.

Work with Chloropsis Consulting LLP on Scientist.com

For prices, more details, or to contact Chloropsis Consulting LLP, visit Scientist.com.